
News
Home>News & Events>Publications>C-Path>Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development
86,118
Related Posts
-
Enrollment of Neonates in More Than One Clinical Trial
-
Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy
-
Challenges and Opportunities to Enhance Global Drug Development in Neonates
-
Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates
-
The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates